CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
1999

CAG Repeat Length in Androgen Receptor Gene and Prostate Cancer

Sample size: 376 publication Evidence: moderate

Author Information

Author(s): Bratt O, Borg Å, Kristoffersson U, Lundgren R, Zhang Q-X, Olsson H

Primary Institution: University of Lund

Hypothesis

Is the length of CAG repeats in the androgen receptor gene related to prostate cancer risk and response to therapy?

Conclusion

Short CAG repeats in the androgen receptor gene are linked to younger age at diagnosis of prostate cancer, but not to increased risk of the disease.

Supporting Evidence

  • Short CAG repeats correlated with younger age at diagnosis of prostate cancer.
  • No significant correlation between CAG repeat length and prostate cancer risk was detected.
  • Patients with long CAG repeats responded better to endocrine therapy.

Takeaway

This study found that men with shorter CAG repeats in a specific gene were diagnosed with prostate cancer at a younger age, but it didn't mean they were more likely to get prostate cancer.

Methodology

A case-control study comparing CAG repeat lengths in prostate cancer patients and female control subjects.

Potential Biases

Potential bias in patient selection for early onset prostate cancer.

Limitations

The study may overestimate prostate cancer risk for men with short CAG repeats due to selection bias.

Participant Demographics

190 prostate cancer patients and 186 female control subjects, all white from southern Sweden.

Statistical Information

P-Value

0.03

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690746

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication